MPLT
Financials
- Market Capitalization 1.69 B
- Employee 133
- Founded 2018
- CEO N/A
- Website www.maplightrx.com
- Headquarter Delaware, United States
- FIGI BBG01JZ5DBQ0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2126 |  GHRS GH Research PLC - Ordinary Shares | 26.94 USD | +0.64% | +0.34% | +32.97% | +90.25% | 1.67 B USD | ||
| 2130 |  FTRE Fortrea Holdings Inc. - Common Stock | 17.92 USD | -0.61% | +5.29% | +7.50% | +275.68% | 1.70 B USD | ||
| 2135 |  ANAB AnaptysBio, Inc. - Common Stock | 55.83 USD | -10.69% | -14.57% | -6.95% | +58.61% | 1.62 B USD | ||
| 2145 |  INVA Innoviva, Inc. - Common Stock | 21.89 USD | +0.69% | -2.41% | -4.70% | +22.84% | 1.62 B USD |
Frequently asked questions about MapLight Therapeutics, Inc. - Common Stock
What is the MapLight Therapeutics, Inc. - Common Stock stock price today?
The current price of MapLight Therapeutics, Inc. - Common Stock (MPLT) is 37.3. Over the past 24 hours, the stock has changed by -1.61%. Follow the MPLT chart for real-time price dynamics.
What is the stock ticker of MapLight Therapeutics, Inc. - Common Stock?
MapLight Therapeutics, Inc. - Common Stock trades under the ticker MPLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MapLight Therapeutics, Inc. - Common Stock stock going up?
MPLT has changed by -3.19% over the last week, +33.36% over the last month, and +96.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MapLight Therapeutics, Inc. - Common Stock net income for the last quarter?
MapLight Therapeutics, Inc. - Common Stock reported net income of -60.67 M for the last quarter. The previous quarter showed -79.55 M, which means net income changed by +23.73%.
How many employees does MapLight Therapeutics, Inc. - Common Stock have?
As of the latest available data, MapLight Therapeutics, Inc. - Common Stock has 133 employees. Workforce size can provide additional context about the company's scale and operations.
What is MapLight Therapeutics, Inc. - Common Stock EBITDA?
MapLight Therapeutics, Inc. - Common Stock EBITDA is -65.16 M, and its EBITDA margin is 1.63 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MapLight Therapeutics, Inc. - Common Stock stock?
You can buy MapLight Therapeutics, Inc. - Common Stock (MPLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MapLight Therapeutics, Inc. - Common Stock stock?
Investing in MapLight Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MPLT chart and related analysis on metatrader.com as part of your research.